Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention.

Publication Year: 2022

DOI:
10.1093/ecco-jcc/jjac034

PMCID:
PMC9097674

PMID:
35553667

Journal Information

Full Title: J Crohns Colitis

Abbreviation: J Crohns Colitis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest A.K. has provided scientific consultancy for Applied Molecular Transport, AstraZeneca, Boehringer Ingelheim, Galapagos, Genentech, GlaxoSmithKline, Glenmark, Gilead Sciences, Hospira, Janssen, Kintai Therapeutics, Novartis, Pfizer, Roche and VHSquared. G.W.S. does not have any conflicts of interest to declare."

Evidence found in paper:

"Funding Research in Professor Kaser’s laboratory has been supported by Wellcome Trust senior investigator awards [106260/Z/14/Z and 222497/Z/21/Z to A.K.]. G.W.S is supported by an Academy of Medical Sciences starter grant for clinical lecturers [SGL022\1008]. This paper was published as part of a supplement financially supported by AbbVie."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025